305 related articles for article (PubMed ID: 25008045)
1. In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies.
Simeonova I; Huillard E
Cell Mol Life Sci; 2014 Oct; 71(20):4007-26. PubMed ID: 25008045
[TBL] [Abstract][Full Text] [Related]
2. Mouse models of medulloblastoma.
Wu X; Northcott PA; Croul S; Taylor MD
Chin J Cancer; 2011 Jul; 30(7):442-9. PubMed ID: 21718590
[TBL] [Abstract][Full Text] [Related]
3. Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice.
Jenkins NC; Rao G; Eberhart CG; Pedone CA; Dubuc AM; Fults DW
J Neurooncol; 2016 Feb; 126(3):415-24. PubMed ID: 26518543
[TBL] [Abstract][Full Text] [Related]
4. Genetically engineered mouse models of brain cancer and the promise of preclinical testing.
Huse JT; Holland EC
Brain Pathol; 2009 Jan; 19(1):132-43. PubMed ID: 19076778
[TBL] [Abstract][Full Text] [Related]
5. In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models.
Kenzelmann Broz D; Attardi LD
Carcinogenesis; 2010 Aug; 31(8):1311-8. PubMed ID: 20097732
[TBL] [Abstract][Full Text] [Related]
6. Hedgehog signaling and the Gli code in stem cells, cancer, and metastases.
Ruiz i Altaba A
Sci Signal; 2011 Nov; 4(200):pt9. PubMed ID: 22114144
[TBL] [Abstract][Full Text] [Related]
7. Genetically engineered human cancer models utilizing mammalian transgene expression.
Kendall SD; Adam SJ; Counter CM
Cell Cycle; 2006 May; 5(10):1074-9. PubMed ID: 16687931
[TBL] [Abstract][Full Text] [Related]
8. c-Myc and beta-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice.
Momota H; Shih AH; Edgar MA; Holland EC
Oncogene; 2008 Jul; 27(32):4392-401. PubMed ID: 18372915
[TBL] [Abstract][Full Text] [Related]
9. A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.
Staal JA; Pei Y; Rood BR
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775567
[TBL] [Abstract][Full Text] [Related]
10. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.
Hambardzumyan D; Becher OJ; Rosenblum MK; Pandolfi PP; Manova-Todorova K; Holland EC
Genes Dev; 2008 Feb; 22(4):436-48. PubMed ID: 18281460
[TBL] [Abstract][Full Text] [Related]
11. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
[TBL] [Abstract][Full Text] [Related]
12. Genetically engineered mouse models of diffuse gliomas.
Schmid RS; Vitucci M; Miller CR
Brain Res Bull; 2012 May; 88(1):72-9. PubMed ID: 21684324
[TBL] [Abstract][Full Text] [Related]
13. RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer.
Knudsen ES; McClendon AK; Franco J; Ertel A; Fortina P; Witkiewicz AK
Cell Cycle; 2015; 14(1):109-22. PubMed ID: 25602521
[TBL] [Abstract][Full Text] [Related]
14. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
[TBL] [Abstract][Full Text] [Related]
15. Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts.
Pöschl J; Stark S; Neumann P; Gröbner S; Kawauchi D; Jones DT; Northcott PA; Lichter P; Pfister SM; Kool M; Schüller U
Acta Neuropathol; 2014 Jul; 128(1):123-36. PubMed ID: 24871706
[TBL] [Abstract][Full Text] [Related]
16. 20 years studying p53 functions in genetically engineered mice.
Donehower LA; Lozano G
Nat Rev Cancer; 2009 Nov; 9(11):831-41. PubMed ID: 19776746
[TBL] [Abstract][Full Text] [Related]
17. Modeling the therapeutic efficacy of p53 restoration in tumors.
Martins CP; Brown-Swigart L; Evan GI
Cell; 2006 Dec; 127(7):1323-34. PubMed ID: 17182091
[TBL] [Abstract][Full Text] [Related]
18. Harnessing genetically engineered mouse models for preclinical testing.
Robles AI; Varticovski L
Chem Biol Interact; 2008 Jan; 171(2):159-64. PubMed ID: 17362899
[TBL] [Abstract][Full Text] [Related]
19. Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer.
McCubrey JA; Rakus D; Gizak A; Steelman LS; Abrams SL; Lertpiriyapong K; Fitzgerald TL; Yang LV; Montalto G; Cervello M; Libra M; Nicoletti F; Scalisi A; Torino F; Fenga C; Neri LM; Marmiroli S; Cocco L; Martelli AM
Biochim Biophys Acta; 2016 Dec; 1863(12):2942-2976. PubMed ID: 27612668
[TBL] [Abstract][Full Text] [Related]
20. Using mice to decipher the molecular genetics of brain tumors.
Hesselager G; Holland EC
Neurosurgery; 2003 Sep; 53(3):685-94; discussion 695. PubMed ID: 12943584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
